Advertisement

Topics

Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance

07:00 EST 28 Feb 2018 | BioMedReports - Blog

Valeant Pharmaceuticals International, Inc. (NYSE: VRXand TSX: VRX) ("Valeant" or the "Company" or "we") today announced its fourth-quarter and full-year 2017 financial results.

"2017

Read more...

Original Article: Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance

NEXT ARTICLE

More From BioPortfolio on "Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance"

Advertisement
Quick Search
Advertisement
Advertisement